Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltitrexed and Oxaliplatin TACE for Advanced Colorectal Cancer
NCT01959061Phase 4Unknown
- Sponsor
- Nanjing Chia-Tai Tianqing Pharmaceutical
- Start
- Sep 2013
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltitrexed in metastatic colorectal cancer (mCRC), sponsored by Nanjing Chia-Tai Tianqing Pharmaceutical. Status: unknown.
02
Drugs
raltitrexed
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01959061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01959061.